Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Corcept Therapeutics
Corcept Therapeutics
Merck Sharp & Dohme LLC
NGM Biopharmaceuticals, Inc
Ohio State University Comprehensive Cancer Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University Hospital, Ghent
Celgene
Ohio State University Comprehensive Cancer Center
GOG Foundation
University of California, San Francisco
Southeastern Gynecologic Oncology